CXCR4 antagonists（Ermium Therapeutics）
N/A
Report date: 2023/02/18 19:35:14
Base Information
Drug NameCXCR4 antagonists（Ermium Therapeutics）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesErmium Therapeutics SAS
China Registration ClassN/A
Develop Information
Active CompaniesErmium Therapeutics SAS
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A